UWM Hldgs (NYSE:UWMC) Stock, Quote.Headers.trade-ideas

UWM Hldgs

UWM Holdings Corp engages in the origination, sale and servicing of residential mortgage loans. The company provides independent mortgage advisors across the states and the district of Columbia.

homebuilders-ai2

Real Estate

UWMC

Homebuyers are hesitant due to expected decline in mortgage rates, causing slow sales. Refinancing activity also shows slight decline.

Homebuyers Turn Screws On Builders As Mortgage Rates Are Telegraphed To Fall

Dell Technologies

Long Ideas

News

Markets

Media

Trading Ideas

ACAD

DELL

LCID

SOFI

Cramer gives his take on E.l.f Beauty, Acadia Pharmaceuticals, B&amp;G Foods, Lucid, SoFi, Dell, Johnson &amp; Johnson, UWM and Symbotic.

Jim Cramer Believes In Dell CEO, Doesn&#39;t Like B&amp;G Foods

xr:d:DAE9HpS4rJc:11789,j:6572294904333961230,t:24013020

Analyst Color

Equities

Mid Cap

REIT

Sector ETFs

Small Cap

Treasuries

Econ #s

Federal Reserve

ETFs

MORT

iShares FTSE NAREIT Mortgage PLUS Capped Index Fund

iShares FTSE NAREIT Residential PLUS Capped Index Fund

Mortgage rates hit 1-year low, benefiting homebuyers &amp; existing homeowners. Goldman Sachs predicts higher home prices due to Fed rate cuts.

Mortgage Rates Fall To Lowest Level In Over A Year, Ease Pressure On Homebuyers: &#39;Good News For Home Price Appreciation&#39;

UWM Holdings Corporation Class A Common Stock

UWM Holdings Corp

<p>This platform is intended to enable Plug to access capital by leveraging its equipment asset base and to provide equipment financing solutions to Plug&#39;s customers to support equipment sales growth.&nbsp;</p>
<p>As a first step in this platform, Plug signed three separate sale and leaseback transactions equivalent to ~$44 million&nbsp;with GTL Leasing, a portfolio company of Antin Infrastructure Partners.</p>
<p>These transactions enable Plug to retain access to crucial hydrogen equipment while strengthening its financial position. The funds generated will be reinvested into Plug&#39;s core operations and focused on driving long-term growth and expansion initiatives.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>


PLUG

Plug Power Reveals Establishment Of An Equipment Leasing Platform And Is Targeting Over $150M In The Near To Mid-term

Health Care

Financing

Offerings

General

VVOS

Vivos Therapeutics Announced A Registered Offering Of $4.3M Selling 1.36M Shares At $3.15 Per Share

<p>In his role as CFO, Dobson will help EVgo solidify its path to profitability as it continues to expand its nationwide network.</p>


Management

EVGO

EVgo Appoints Paul Dobson As CFO, Effective October 1, 2024

Biotech

ACHL

Achilles Therapeutics Discontinued Its TIL-Based cNeT Program And Closed Phase 1/2A CHIRON and THETIS Trials, And It Will Refocus Its Strategy To Explore Further Engagement With Third Parties, The Company Has Engaged BofA Securities To Provide Strategic Financial Advice

Buybacks

AerCap Holdings Plans New $500M Share Repurchase Program, Which Will Run Through March 31, 2025

<p>Piper Sandler  analyst Adam Maeder   initiates coverage on Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with a Overweight rating and announces Price Target of $131.</p>


Price Target

Initiation

Analyst Ratings

Piper Sandler Initiates Coverage On Abbott Laboratories with Overweight Rating, Announces Price Target of $131

<p>Working together with NVIDIA, SLB will build and optimize models to the specific needs and requirements of the data-intensive energy industry, including subsurface exploration, production operations and data management.&nbsp;</p>


NVDA

SLB, NVIDIA Partner To Develop Generative AI Solutions For The Energy Industry

<p>Chinese EV maker <strong>Nio Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is reportedly eyeing taking over <strong>Volkswagen</strong> brand <strong>Audi</strong>&#8216;s car plant in Vorst, a city in Brussels.</p>
<p><strong>What Happened:</strong> A Nio delegation visited the Vorst plant in recent weeks and is working on a bid to submit to Audi parent Volkswagen by next Monday, <a href="https://www.tijd.be/ondernemen/auto/chinees-nio-kandidaat-overnemer-voor-audi-brussels-fabriek/10565046.html">reported</a> Belgian newspaper De Tijd. Belgium-based <strong>D&#8217;Ieteren</strong> is also interested in the plant, the report said.</p>
<p>Volkswagen has decided not to make any more vehicles at the plant after the last Q8 e-tron SUV rolls off the production line next year. Unless the German automaker finds a buyer, the plant will be closed, leaving 2,910 employees unemployed, the report said. </p>
<p><strong>Why It Matters:</strong> For Nio, having a plant in Europe will help it avoid the high tariffs being considered for EV imports from China. </p>
<p>The European Commission is <a href="https://www.benzinga.com/news/24/09/40810974/us-ally-urges-eu-to-reconsider-tariffs-on-chinese-evs-we-dont-need-another-war">expected to propose </a>final tariffs of up to 35.3% on electric vehicles manufactured in China, in addition to the standard 10% car import duty applied by the EU.&nbsp;</p>
<p>The Chinese EV maker started<a href="https://www.benzinga.com/markets/equities/24/09/40925180/teslas-chinese-competitor-nio-begins-deliveries-of-new-es8-in-europe-amid-eu-tariff-concerns-rep"> delivering the ES8 SUV </a>to customers in Europe earlier this month. The vehicle is referred to as the EL8 in the geography due to an older lawsuit with Audi. </p>
<p><em>Check out more of Benzinga's Future Of Mobility coverage by&nbsp;</em><a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener"><em>following this link</em></a>.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/24/09/40933228/tesla-registrations-in-eu-take-a-hit-in-2024-as-ev-demand-slows-volkswagen-volvo-and-toyota-continue">Tesla Registrations In EU Take A Hit In 2024 As EV Demand Slows: Volkswagen, Volvo, And Toyota Continue To Gain Speed</a></strong></li>
</ul>
<p><em>Photo courtesy: Shutterstock</em></p>


Tech

Chinese EV Maker Nio Eyes Audi's Brussels Plant Amid European Expansion: Report

UBER

Darden Restaurants Inks Pact With Uber To Introduce On-Demand Delivery, with Olive Garden The First To Pilot

GOEV

Canoo Announced That The U.S. Customs And Border Protection Has Officially Approved Final Activation Of Canoo's Oklahoma City Operations As A Foreign-Trade Zone, Becoming One Of The Largest FTZs In The State Of Oklahoma

<p>Bernstein  analyst Aneesha Sherman   maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Outperform and lowers the price target from $112 to $109.</p>


Bernstein Maintains Outperform on Nike, Lowers Price Target to $109

BLDR

Builders FirstSource Names Pete Beckmann To Succeed Peter Jackson As CFO

<p>The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.</p>
<p>Here's the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3 class="wp-block-heading"><strong>Gran Tierra Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTE#NYSE">GTE</a>)</strong></h3>
<ul>
<li>On Sept. 18, Gran Tierra Energy announced the closing of an additional $150 million aggregate principal amount of its 9.500% senior secured amortizing notes due 2029. The company's stock fell around 31% over the past month and has a <a href="https://www.benzinga.com/quote/GTE">52-week low of $4.72</a>.</li>
<li><strong>RSI Value:</strong> 27.50</li>
<li><strong>GTE Price Action:</strong> Shares of Gran Tierra Energy fell 6.4% to close at $5.90 on Wednesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">latest GTE new</a>s. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="846" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149.png" alt="" class="wp-image-555845" style="width:682px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070435/image-149-768x716.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Vivakor inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIVK#NASDAQ">VIVK</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></h3>
<ul>
<li>On April 22, VirnetX Holding announced that it has established an advisory board comprised of four retired senior U.S. Air Force leaders. The company's stock fell around 28% over the past month. It <a href="https://www.benzinga.com/quote/VIVK">has a 52-week low</a> of $0.44.</li>
<li><strong>RSI Value:</strong> 27.07</li>
<li><strong>VIVK Price Action:</strong> Shares of Vivakor fell 0.7% to close at $1.43 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"> trend in Vivakor stock</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150.png" alt="" class="wp-image-555846" style="width:657px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070512/image-150-768x702.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>Crown LNG Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>)</strong></h3>
<ul>
<li>On Sept. 17, Crown LNG announced it received a Nasdaq notification regarding Nasdaq listing rule 5550(a)(2) for failing to meet its minimum bid requirements. The company's shares fell around 45% over the past month and has a 52-week<a href="https://www.benzinga.com/quote/GGR"> low of $0.26</a>.</li>
<li><strong>RSI Value:</strong> 22.60</li>
<li><strong>CGBS Price Action:</strong> Shares of Crown LNG Holdings fell 10.6% to close at $0.26 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1">breakout in Crown LNG Holdings share</a>s.  </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent091924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151.png" alt="" class="wp-image-555848" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/19070540/image-151-768x729.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure></p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/news/earnings/24/09/40925678/fedex-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-an">FedEx Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></strong></li>
</ul>


Pre-Market Outlook

CGBS

VIVK

Top 3 Energy Stocks That Could Lead To Your Biggest Gains This Month

Stock Split

BBGI

Beasley Broadcast Has Approved A Reverse Stock Split At A Ratio Of 1-for-20

Guidance

Darden Restaurants Reiterated Full Year Financial Outlook For Fiscal 2025: Sees Net Earnings Per Share From Continuing Operations Of $9.40 To $9.60

<p>Jackson will succeed Dave Rush, who has served as CEO since November 2022 and is retiring after 25 years of dedicated service to the Company. Rush will remain on the Builders FirstSource Board of Directors and continue as a special advisor to ensure a smooth transition.</p>


Builders FirstSource Names CFO Peter Jackson As Its Next President & CEO And Member Of Its Board Of Directors, Effective November 6, 2024

ENSC

Ensysce Biosciences Has Submitted To FDA Its PF614-301 Protocol Of The Study To Evaluate The Efficacy And Safety Of PF614 For Moderate To Severe Pain After Abdominoplasty

Earnings

MoneyHero Q2 Sales $20.67M Up From $16.65M YoY

<p>Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) reported quarterly earnings of $1.75 per share which missed the analyst consensus estimate of $1.83 by 4.37 percent. This is a 1.69 percent decrease over earnings of $1.78 per share from the same period last year.  The company reported quarterly sales of $2.76 billion which missed the analyst consensus estimate of $2.80 billion by 1.54 percent.  This is a 0.95 percent increase over sales of $2.73 billion the same period last year.</p>


Earnings Misses

Darden Restaurants Q1 Adj $1.75 Misses $1.83 Estimate, Sales $2.76B Miss $2.80B Estimate

TNXP

Tonix Pharmaceuticals Secures US Patent Claiming Pharmaceutical Composition, Method Of Treating Migraine Via Intranasal Administration, And An Intranasal Delivery System For Tosymra. This Patent, Excluding Possible Patent Term Extensions, Is Expected To Expire In 2030.

In a report released yesterday, Bose George from KBW maintained a Hold rating on UWM Holding (UWMC – Research Report), with a price target of $8.00...

KBW Keeps Their Hold Rating on UWM Holding (UWMC)

Analysts fell to the sidelines weighing in on UWM Holding (UWMC – Research Report) and Travelers Companies (TRV – Research Report) with neutral rat...

Wall Street Analysts Are Neutral on Top Financial Picks

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on UWM Holding (UWMC – Research Report), Upstart Holdi...

Analysts' Opinions Are Mixed on These Financial Stocks: UWM Holding (UWMC), Upstart Holdings (UPST) and Regions Financial (RF)

In a report released today, Terry Ma from Barclays maintained a Sell rating on UWM Holding (UWMC – Research Report), with a price target of $6.00. ...

Barclays Remains a Sell on UWM Holding (UWMC)

Morgan Stanley analyst James Faucette maintained a Hold rating on UWM Holding (UWMC – Research Report) today and set a price target of $6.00. The c...

UWM Holding (UWMC) Receives a Hold from Morgan Stanley

Warning: UWMC is at high risk of performing badly

UWM Holdings Corporation 2024 Q2 - Results - Earnings Call Presentation

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Investment bank Wedbush may be best-known for its sell-side coverage of high-profile <a href="https://investorplace.com/industries/technology/">tech stocks</a> like <strong>Tesla</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/tsla-stock-quote/"><strong>TSLA</strong></a></span>), but taking a look at the new Wedbush price targets, you&rsquo;ll find that the EV maker is not on this list.</p>



<p>Neither are many of the other well-known names in tech. Instead, with some exceptions, most of the latest stocks receiving either a target price increase or a target price decrease from Wedbush this month are in other sectors. For instance, sectors like health care, real estate, consumer discretionary, and financial services are also included.</p>



<p>So, should one consider their recommendations? <span>Much as was the case back in May when I broke down several stocks that had </span>just received&nbsp;price target decreases&nbsp;from Wedbush, the answer to the question &ldquo;Should you take heed of their advice?&rdquo; is largely the same.</p>



<p>Put simply, it depends. By examining each of the following seven new Wedbush price targets, we can see whether to follow their lead or take an opposite stance.</p>



<h2>Apellis Pharmaceuticals (APLS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3-300x169.jpg" alt="Photo of test tubes and droplet with purple and reddish-orange sunset visual effect, representing biotech"><div>Source: shutterstock.com/Romix Image</div></div><p><strong>Apellis Pharmaceuticals</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/apls-stock-quote/"><strong>APLS</strong></a></span><span>) is a commercial-stage biotech firm. The</span> company&rsquo;s two key products are Empaveli and Syfovre. Both of these therapies are for the treatment of rare autoimmune and inflammatory diseases.</p>



<p>On Aug. 9, Wedbush reiterated its &ldquo;neutral&rdquo; rating on APLS stock but raised its price target from $38 to $41 per share. This increased price target follows some promising news about a treatment in Apellis&rsquo; pipeline. The previous day, Apellis and its strategic partner <strong>Swedish Orphan Biovitrum</strong> (OTCMKTS:<span><strong>SWOBY</strong></span>) revealed <a href="https://seekingalpha.com/news/4137092-apellis-stock-jumps-as-rare-kidney-disease-therapy-succeeds-in-trial">promising Phase 3 clinical trial data</a>. This data could pave the way for the company to obtain regulatory approval to sell Empaveli as a treatment for several rare kidney diseases. As analysts at Evercore ISI recently put it, this could mean a <a href="https://www.fiercepharma.com/pharma/apellis-and-sobis-pegcetacoplan-wins-big-rare-kidney-disease-study-offering-renewed-hope-new">&ldquo;blockbuster opportunity&rdquo;</a> for Apellis Pharmaceuticals.</p>



<p>Investing in <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks</a> is risky and complex. Hence, you&rsquo;ll want to conduct deep due diligence before making a trading decision regarding APLS shares. However, Wedbush&rsquo;s cautiously optimistic view, coupled with recent developments, highlights that this may be a worthwhile opportunity for those experienced and well-versed in the ins-and-outs of biotech stock investing.</p>



<h2>Beazer Homes USA (BZH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/homebuilder_stocks_1600-300x169.png" alt="A photo of a man in a mask and neon green vest in front of a home that's under construction."><div>Source: Tong_stocker/ShutterStock.com</div></div><p><strong>Beazer Homes USA</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/bzh-stock-quote/"><strong>BZH</strong></a></span>) is another non-tech name on the list of new Wedbush price targets. On Aug. 2, the sell-side firm reiterated its &ldquo;neutral&rdquo; rating on the homebuilder&rsquo;s shares, but a massive target price increase came alongside this reiteration.</p>



<p>Previously giving BZH stock a $33 per share price target, Wedbush analysts now believe Beazer Homes could climb to as much as <a href="https://www.marketbeat.com/instant-alerts/nyse-bzh-boost-price-target-2024-08-02/">$41 per share</a>. Given the timing of this target price increase, chalk it up to promising aspects of Beazer&rsquo;s latest quarterly earnings release. The results themselves were largely mixed. BZH beat on earnings, yet revenue came in slightly short of expectations. However, in the post-earnings investor presentation, management provided promising updates on community growth and balance sheet improvement.</p>



<p>It&rsquo;s worth noting that Beazer Homes has remained profitable thus far during the recent slowdown in the housing market. Even so, shares continue to trade at a heavily discounted valuation of just 6.6x forward earnings. With this, and assuming that better conditions will arrive once interest rates move lower, Wedbush may be on the money with the aforementioned price target. This price target is nearly 50% above BZH&rsquo;s current trading price.</p>



<h2>Maplebear (CART)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/05/instacart-1600-300x169.png" alt="Instacart logo on a phone screen over a yellow background with a timer, boxes, and a shopping cart. Instacart IPO."><div>Source: Burdun Iliya / Shutterstock</div></div><p><strong>Maplebear</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cart-stock-quote/"><strong>CART</strong></a></span><span>), which operates Instacart, is yet another situation in which the price target has changed</span> but not the sell-side rating. On Aug. 7, Wedbush reiterated its &ldquo;neutral rating&rdquo; on the grocery delivery app operator&rsquo;s shares, with a price target increase <a href="https://www.marketbeat.com/instant-alerts/nasdaq-cart-boost-price-target-2024-08-07/">from $35 to $38 per share</a>.</p>



<p>Wedbush&rsquo;s price target adjustment for CART stock follows the Instacart parent&rsquo;s latest quarterly earnings release. The company beat on both revenue and earnings&nbsp;for the June quarter and provided a solid outlook for the current quarter. Wedbush&rsquo;s price target for Maplebear is around 19% above current trading prices. This makes sense, considering both valuation and growth forecasts. At 28.9x forward earnings, CART isn&rsquo;t exactly cheap.</p>



<p>Then again, comparable names trade at higher valuations. <strong>Doordash</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/dash-stock-quote/"><strong>DASH</strong></a></span>), for instance, trades for 42.2x forward earnings. <strong>Uber Technologies</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/uber-stock-quote/"><strong>UBER</strong></a></span>) trades at a forward multiple of 65.8x. Also, considering that sell-side consensus calls for Maplebear&rsquo;s earnings growth to come in at <a href="https://seekingalpha.com/symbol/CART/earnings">around 20%</a> over the next year, this multiple may be sustainable, with shares rising in line with bottom-line growth.</p>



<h2>Cyberark Software (CYBR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/cybr-stock-1-300x169.jpg" alt="Cyberark (CYBR) logo on a corporate building"><div>Source: photobyphm / Shutterstock.com</div></div><p>Already bullish on <strong>Cyberark Software</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/cybr-stock-quote/"><strong>CYBR</strong></a></span><span>), Wedbush upped the ante on Aug. 9, with a target price increase from $285 to $300 per share. As you may have guessed, Wedbush&rsquo;s upward adjustment to its price target follows</span> Cyberark&rsquo;s latest quarterly earnings release.</p>



<p><span>This cyber security software company reported&nbsp;<a href="https://seekingalpha.com/news/4137237-cyberark-jumps-as-q2-tops-expectations-ups-guidance" target="_blank">&ldquo;beat and raise&rdquo;</a>&nbsp;results in the release</span>. CYBR stock rallied as a result, surging 8% higher on earnings day. Wedbush isn&rsquo;t the only sell-side firm singing the praises of Cyberark Software. Calling CYBR a <a href="https://www.cnbc.com/2024/08/09/bank-of-america-says-buy-this-diamond-in-the-rough-cybersecurity-stock.html">&ldquo;diamond in the rough&rdquo;</a> among <a href="https://investorplace.com/industries/technology/cybersecurity/">cybersecurity stocks</a>, analysts at Bank of America argued that shares have more than 25% upside, far greater than Wedbush&rsquo;s own take on the stock.</p>



<p>Yet, while analysts and investors are very positive on Cyberark right now, keep in mind the valuation risk with this stock. CYBR trades for 118.9x forward earnings. This valuation may be sustainable as the growth story remains in motion for Cyberark. However, perhaps in &ldquo;priced for perfection&rdquo; territory, any sort of hiccup or misstep in subsequent results could lead to a tremendous drop in price for CYBR, which is up by more than 90% over the past year.</p>



<h2>Expedia Group (EXPE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/expe_expedia_1600_1739158757-300x169.png" alt="Expedia app logo on a smartphone screen. EXPE stock"><div>Source: NYC Russ / Shutterstock.com</div></div><p>An exception to the trend mentioned earlier, <strong>Expedia Group</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/expe-stock-quote/"><strong>EXPE</strong></a></span>) is one of a few tech stocks that are among the names with new Wedbush price targets this month. On Aug. 9, the sell-side firm maintained a neutral rating on the online travel company&rsquo;s shares, but raised its price target from $125 to $130 per share.</p>



<p>This is yet another post-earnings price target increase. On Aug. 8, Expedia reported a revenue and earnings beat, although <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40288024/expedias-q2-triumph-analysts-highlight-vrbo-as-bright-spot-praise-growth-in-busines">updates to guidance fell short of expectations</a>. Still, investors reacted positively to earnings. In the days following the earnings release, EXPE stock soared from the low-$110s up to above $130 per share, in line with Wedbush&rsquo;s new price target.</p>



<p>But while this suggests that there&rsquo;s little in the way of near-term upside, you may not want to jump to that conclusion. Despite the market&rsquo;s resurging optimism, shares keep trading at a discounted valuation of only 11.1 times forward earnings. If subsequent results are better than feared, and the travel economy continues to perform strongly despite economic slowdown concerns, shares may have a strong chance of soaring again, thanks to positive surprises.</p>



<h2>Under Armour (UAA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/01/uaa1600b-300x169.jpg" alt="the exterior of an Under Armour store"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>On Aug. 9, Wedbush issued a slight price target increase for shares in athletic apparel company <strong>Under Armour</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/uaa-stock-quote/"><strong>UAA</strong></a></span>). Reiterating its &ldquo;outperform&rdquo; rating, the firm increased its price target for UAA from $8 to $8.50 per share. There is logic to this slight price target tweak.</p>



<p>Although the results show that challenges remain for the company, Under Armour <a href="https://www.bloomberg.com/news/videos/2024-08-08/under-armour-s-shares-surge-as-restructuring-progresses">beat expectations</a> with its previous quarter&rsquo;s numbers. The results, guidance and other updates have also increased confidence in Under Armour&rsquo;s turnaround efforts, led by founder and returning CEO Kevin Plank. Previously, Wedbush&rsquo;s price target was well above the UAA stock price. However, with shares soaring higher after earnings, even with the adjustment UAA, is now within range of the target.</p>



<p>That said, there may be far greater upside with Under Armour stock than you think. After all, it was only a few years ago that UAA traded for prices north of $25 per share. The stock commanded even higher prices during the 2010s. Even if the company never re-hits its former glory, it may not take much improvement to send shares materially above current price levels.</p>



<h2>UWM Holdings (UWMC)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/reit1600d-300x169.jpg" alt="a wooden house shape holds 3 bags of cash representing reits to buy"><div>Source: Shutterstock</div></div><p><span>Wedbush analysts have become more bullish on housing and&nbsp;<a href="https://investorplace.com/industries/real-estate/" target="_blank">real estate stocks, anticipating lower interest rates ahead</a></span>. Many real estate investment trusts are among the new Wedbush price targets, as are shares in mortgage wholesaler <strong>UWM Holdings</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/uwmc-stock-quote/"><strong>UWMC</strong></a></span>).</p>



<p>On Aug. 7, Wedbush increased its UWMC stock price target from $7 to $8.50 per share, while maintaining a &ldquo;neutral&rdquo; rating on shares. With shares currently trading around this price target, this suggests little near-term upside. In this situation, I agree with this assessment. A stronger housing market may perhaps be just around the corner. As I have pointed out previously, factors such as UWM&rsquo;s sponsorship of the WNBA could help the company report better-than-expected results.</p>



<p>Nevertheless, one can argue that improved results are already baked into UWMC&rsquo;s valuation. Shares today trade for around 33x estimated 2024 earnings, and 21.5x estimated 2025 earnings. With peers like <strong>Mr. Cooper Group</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/coop-stock-quote/"><strong>COOP</strong></a></span>) trading at forward multiples in the single digits, even if you&rsquo;re bullish on a housing recovery, there may be better choices than UWMC.</p>



<p><em>On the date of publication, Thomas Niel did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a><em>.</em></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
<p>The post <a href="https://investorplace.com/2024/08/wedbush-just-raised-price-target-on-these-seven-stocks/">Wedbush Just Raised its Price Target on These 7 Stocks: August 12, 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Wedbush Just Raised its Price Target on These 7 Stocks: August 12, 2024

Analyst Eric Hagen of BTIG maintained a Buy rating on UWM Holding (UWMC – Research Report), with a price target of $10.00. Eric Hagen has given his...

Buy Rating Affirmed for UWM Holding Amid Anticipated Mortgage Rate Decline and Operational Efficiency

Today we got a taste of that as markets re-price the impact of the Fed rate cuts due to kick in in a few weeks. A strong barrage of selling hit stocks - flattening marquee growth and tech names, especially.

September Is Showing Us Just How Rough It Can Be

AAPL

APLS

CART

CYBR

EXPE

GOOGL

MARA

MSTR

UPST

Press Releases

UWM Holdings Corporation Announces Q4 2023 and Full Year 2023 Earnings Conference Call

UWM Holdings Corporation Announces Fourth Quarter & Full Year 2023 Results

The Law Offices of Frank R. Cruz Announces Investigation of UWM Holdings Corporation (UWMC) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of UWM Holdings Corporation (UWMC) on Behalf of Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of UWM Holdings Corporation (UWMC) on Behalf of Investors

Legal

UWM ALERT: Bragar Eagel & Squire, P.C. is Investigating UWM Holdings Corporation on Behalf of UWM Stockholders and Encourages Investors to Contact the Firm

UWM Holdings Corporation Announces Q1 2024 Earnings Conference Call

UWM Holdings Corporation Announces First Quarter 2024 Results

UWM Holdings Corporation Announces 2Q 2024 Earnings Conference Call

UWM Holdings Corporation Announces Second Quarter 2024 Results

Enact Holdings

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural

Better Home & Finance Holding Company - Class A Common Stock

Better Home & Finance

CNFinance Holdings Limited American Depositary Shares, each representing twenty (20) Ordinary Shares

CNFinance Hldgs

Mr. Cooper Gr

Essent Group

Finance of America Companies Inc. Class A Common Stock

Finance of America

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

UWM Hldgs

UWM Hldgs (UWMC) Forecast

UWM Hldgs (NYSE:UWMC) Stock, Quote.Headers.trade-ideas